Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: Data from the MRC BRIGHT Study

Clinical Endocrinology

Volumn 67, Issue 6, 2007, Pages 832-838

  Freel, E M ^a   Ingram, M ^a   Friel, E C ^a   Fraser, R ^a   Brown, M ^b   Samani, N J ^c   Caulfield, M ^d   Munroe, P ^d   Farrall, M ^e   Webster, J ^f   Clayton, D ^b   Dominiczak, A F ^a   Davies, E ^a   Connell, J M C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; CORTICOSTEROID; STEROID 11BETA MONOOXYGENASE;

ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMOGRAPHY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENOTYPE; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADRENOCORTICOTROPIC HORMONE; AGED; ALDOSTERONE; ALDOSTERONE SYNTHASE; ALLELES; CORTODOXONE; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; STEROID 11-BETA-HYDROXYLASE;

EID: 36248979113     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02971.x     Document Type: Article

References (41)

1. Hiramatsu, K., Yamada, T., Yukimura, Y., Komiya, I., Ichikawa, K., Ishihara, M., Nagata, H. Izumiyama, T. (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Archives of Internal Medicine, 141, 1589 1593.
2. Gordon, R.D., Stowasser, M., Tunny, T.J., Klemm, S.A. Rutherford, J.C. (1994) High incidence of primary aldosteronism in 199 patients referred with hypertension. Clinical and Experimental Pharmacology and Physiology, 21, 315 318.
3. Lim, P.O., Rodgers, P., Cardale, K., Watson, A.D. Macdonald, T.M. (1999) Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet, 353, 40.
4. Fardella, C.E., Mosso, L., Gomez-Sanchez, C., Cortes, P., Soto, J., Gomez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A. Montero, J. (2000) Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. Journal of Clinical Endocrinology and Metabolism, 85, 1863 1867.
5. Rayner, B.L., Opie, L.H. Davidson, J.S. (2000) The aldosterone/renin ratio as a screening test for primary aldosteronism. South African Medical Journal, 90, 394 400.
6. Schwartz, G.L., Chapman, A.B., Boerwinkle, E., Kisabeth, R.M. Turner, S.T. (2002) Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clinical Chemistry, 48, 1919 1923.
7. Olivieri, O., Ciacciarelli, A., Signorelli, D., Pizzolo, F., Guarini, P., Pavan, C., Corgnati, A., Falcone, S., Corrocher, R., Micchi, A., Cressoni, C. Blengio, G. (2004) Aldosterone to renin ratio in a primary care setting: the Bussolengo study. Journal of Clinical Endocrinology and Metabolism, 89, 4221 4226.
8. Struthers, A.D. (2004) The clinical implications of aldosterone escape in congestive heart failure. European Journal of Heart Failure, 6, 539 545.
9. Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J. Wittes, J. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine, 341, 709 717.
10. Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J. Gatlin, M. (2003) Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators: eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine, 348, 1309 1321.
11. Milliez, P., Girerd, X., Plouin, P.F., Blacher, J., Safar, M.E. Mourad, J.J. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. Journal of the American College of Cardiology, 45, 1243 1248.
12. Lifton, R.P., Dluhy, R.G., Powers, M., Rich, G.M., Cook, S., Ulick, S. Lalouel, J.M. (2005) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature, 355, 262 265.
13. White, P.C. (2001) Steroid 11 beta-hydroxylase deficiency and related disorders. Endocrinology and Metabolism Clinics of North America, 30, 61 79.
14. Cicila, G.T., Rapp, J.P., Wang, J.M., St Lezin, E., Ng, S.C. Kurtz, T.W. (1993) Linkage of 11 beta-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nature Genetics, 3, 346 353.
15. Mornet, E., Dupont, J., Vitek, A. White, P.C. (1989) Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). Journal of Biological Chemistry, 264, 20961 20967.
16. Lim, P.O., Macdonald, T.M., Holloway, C., Friel, E., Anderson, N.H., Dow, E., Jung, R.T., Davies, E., Fraser, R. Connell, J.M. (2002) Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. Journal of Clinical Endocrinology and Metabolism, 87, 4398 4402.
17. Tamaki, S., Iwai, N., Tsujita, Y. Kinoshita, M. (1999) Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension, 33, 266 270.
18. Tsukada, K., Ishimitsu, T., Teranishi, M., Saitoh, M., Yoshii, M., Inada, H., Ohta, S., Akashi, M., Minami, J., Ono, H., Ohrui, M. Matsuoka, H. (2002) Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension. Journal of Human Hypertension, 16, 789 793.
19. Davies, E., Holloway, C.D., Ingram, M.C., Inglis, G.C., Friel, E.C., Morrison, C., Anderson, N.H., Fraser, R. Connell, J.M. (1999) Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension, 33, 703 707.
20. Paillard, F., Chansel, D., Brand, E., Benetos, A., Thomas, F., Czekalski, S., Ardaillou, R. Soubrier, F. (1999 1999) Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension, 34, 423 429.
21. Pojoga, L., Gautier, S., Blanc, H., Guyene, T.T., Poirier, O., Cambien, F. Benetos, A. (1998) Genetic determination of plasma aldosterone levels in essential hypertension. American Journal of Hypertension, 11, 856 860.
22. Davies, E., Holloway, C.D., Ingram, M.C., Friel, E.C., Inglis, G.C., Swan, L., Hillis, W.S., Fraser, R. Connell, J.M. (2001) An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clinical Endocrinology, 54, 813 817.
23. Hautanena, A., Lankinen, L., Kupari, M., Janne, O.A., Adlercreutz, H., Nikkila, H. White, P.C. (1998) Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. Journal of Internal Medicine, 244, 11 18.
24. Freel, E.M. Connell, J.M.C. (2004) Mechanisms of hypertension: the expanding role of aldosterone. Journal of the American Society of Nephrology, 15, 1993 2001.
25. White, P.C. Rainey, W.E. (2005) Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. Journal of Clinical Endocrinology and Metabolism, 90, 1252 1255.
26. Caulfield, M., Munroe, P., Pembroke, J., Samani, N., Dominiczak, A., Brown, M., Benjamin, N., Webster, J., Ratcliffe, P., O'Shea, S., Papp, J., Taylor, E., Dobson, R., Knight, J., Newhouse, S., Hooper, J., Lee, W., Brain, N., Clayton, D., Lathrop, G.M., Farrall, M. Connell, J. (2003) MRC British Genetics of Hypertension Study. Genome-wide mapping of human loci for essential hypertension. Lancet, 361, 2118 2123.
27. Shackleton, C.H. (1993) Mass spectrometry in the diagnosis of steroid-related disorders and in hypertension research. Journal of Steroid Biochemistry and Molecular Biology, 45, 127 140.
28. de Simone, G., Tommaselli, A.P., Rossi, R., Valentino, R., Lauria, R., Scopacasa, F. Lombardi, G. (1985) Partial deficiency of adrenal 11-hydroxylase: a possible cause of primary hypertension. Hypertension, 7, 204 210.
29. Connell, J.M., Jamieson, A.J., Davies, E., Ingram, M., Soro, A. Fraser, R. (1996) 11 beta-hydroxylase activity in glucocorticoid suppressible hyperaldosteronism: lessons for essential hypertension? Endocrine Research, 22, 691 700.
30. Ganapathipillai, S., Laval, G., Hoffmann, I.S., Castejon, A.M., Nicod, J., Dick, B., Frey, F.J., Frey, B.M., Cubeddu, L.X. Ferrari, P. (2005) CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. Journal of Clinical Endocrinology and Metabolism, 90, 1220 1225.
31. Inglis, G.C., Ingram, M.C., Holloway, C.D., Swan, L., Birnie, D., Hillis, W.S., Davies, E., Fraser, R. Connell, J.M. (1999) Familial pattern of corticosteroids and their metabolism in adult human subjects - the Scottish Adult Twin Study. Journal of Clinical Endocrinology and Metabolism, 84, 4132 4137.
32. White, P.C. (1994) Disorders of aldosterone biosynthesis and action. New England Journal of Medicine, 331, 250 258.
33. Hollenberg, N.K., Williams, G., Burger, B. Hooshmand, I. (1975) The influence of potassium on the renal vasculature and the adrenal gland, and their responsiveness to angiotensin II in normal man. Clinical Science and Molecular Medicine, 49, 527 534.
34. Connell, J.M., Whitworth, J.A., Davies, D.L., Lever, A.F., Richards, A.M. Fraser, R. (1987) Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man. Journal of Hypertension, 5, 425 433.
35. Oelkers, W. (1985) Prolonged ACTH infusion suppresses aldosterone secretion in spite of high renin activity. Acta Endocrinologica, 108, 91 97.
36. Miller, W.L. (1988) Molecular biology of steroid hormone synthesis. Endocrine Reviews, 9, 295 318.
37. Lightman, S.L., James, V.H., Linsell, C., Mullen, P.E., Peart, W.S. Sever, P.S. (1981) Studies of diurnal changes in plasma renin activity, and plasma noradrenaline, aldosterone and cortisol concentrations in man. Clinical Endocrinology, 14, 213 223.
38. + exchange in Cushing's syndrome reflects functional hypermineralocorticoidism. Journal of Hypertension, 16, 1187 1191.
39. Yamakita, N., Mune, T., Morita, H., Yasuda, K., Miura, K. Gomez-Sanchez, C.E. (1994) Plasma 18-oxocortisol levels in the patients with adrenocortical disorders. Clinical Endocrinology, 40, 583 587.
40. Keavney, B., Mayosi, B., Gaukrodger, N., Imrie, H., Baker, M., Fraser, R., Ingram, M., Watkins, H., Farrall, M., Davies, E. Connell, J. (2005) Genetic variation at the locus encompassing 11-beta hydroxylase and aldosterone synthase accounts for heritability in cortisol precursor (11-deoxycortisol) urinary metabolite excretion. Journal of Clinical Endocrinology and Metabolism, 90, 1072 1077.
41. Barr, M., MacKenzie, S.M., Friel, E., Holloway, C.D., Wilkinson, D., Brain, N.J., Ingram, M.C., Fraser, R., Brown, M., Samani, N.J., Caulfield, M., Munroe, P.B., Farrall, M., Webster, J., Clayton, D., Dominczak, A.F., Connell, J. Davies, E. (2007) Polymorphic variation in the 11-beta hydroxylase gene associates with reduced 11-hydroxylase efficiency. Hypertension, 49, 1 7.